IDiyas

For the Inventor, By the Inventor

Minoo, Japan

Isamu Maruyama

USPTO Granted Patents = 26

Average Co-Inventor Count = 5.6

ph-index = 6

Forward Citations = 105(Granted Patents)


Location History:

  • Minoo, JA (1976 - 1978)
  • Minoo, JP (1979 - 1982)
  • Kawanishi, JP (1988 - 1989)

Company Filing History:

goldMedal24 out of 6,892 
 
Sumitomo Chemical Company, Limited
 patents
silverMedal1 out of 174 
 
Sumitomo Pharmaceuticals Company Limited
 patents
bronzeMedal1 out of 1 
 
Sumitono Pharmaceutical Company, Limited
 patent

Years Active: 1976-1989

Loading Chart...
26 patents (USPTO):Explore Patents
1. 4843078 - Succinimide derivatives, and their production and use (1989-06-27),
2. 4745117 - Imide derivatives and compositions for use as antipsychotic agents (1988-05-17),
3. 4325886 - Optical resolution of acylthiopropionic acid (1982-04-20),
4. 4230706 - Antihypertensive quinazoline compounds (1980-10-28),
5. 4148796 - .gamma.-Piperidinobutyrophenones (1979-04-10),
6. 4080328 - N-substituted heterocyclic derivatives and preparation thereof (1978-03-21),
7. 4079053 - Benzodiazepine derivatives (1978-03-14),
8. 4065565 - Acylhydrazones and anti-psychotic compositions thereof (1977-12-27),
9. 4017624 - N-(.omega.-Amino)alkylaniline derivatives (1977-04-12),
10. 4017621 - 2-Morpholinyl tricyclic dibenzazepine compounds (1977-04-12),
11. 4012515 - Aryl ketones and production thereof (1977-03-15),
12. 4012514 - Aryl ketones and production thereof (1977-03-15),
13. 4010280 - Phenoxyalkylamine derivatives and preparation thereof (1977-03-01),
14. 4010154 - Benzodiazepinones (1977-03-01),
15. 4009275 - Phenoxypropylamine derivatives (1977-02-22),

Title: The Innovative Contributions of Isamu Maruyama

Introduction: Isamu Maruyama, an accomplished inventor based in Minoo, Japan, has made significant strides in the field of pharmaceuticals with a portfolio of 26 patents. His work focuses on the development of novel chemical compounds, particularly in the area of mental health treatment.

Latest Patents: Among Maruyama's latest patents are innovative succinimide derivatives. One notable patent describes a succinimide derivative characterized by a specific formula where R represents a pyridyl or pyrimidinyl group, substituted with various functional groups. These derivatives have been recognized for their potential use as anti-anxiety drugs. Another exciting patent involves imide derivatives and compositions aimed at creating effective antipsychotic agents, showcasing Maruyama's commitment to advancing mental health treatments.

Career Highlights: Maruyama has amassed considerable experience working with prominent companies such as Sumitomo Chemical Company, Limited and Sumitomo Pharmaceuticals Company Limited. His contributions to these organizations have been integral in pushing forward pharmaceutical innovations and enhancing drug efficacy.

Collaborations: Throughout his career, Isamu Maruyama has collaborated with notable colleagues, including Hisao Yamamoto and Masaru Nakao. These partnerships have fostered a productive environment that encourages innovation and the sharing of ideas in the field of pharmaceuticals.

Conclusion: Isamu Maruyama's dedication to innovation is reflected in his extensive patent portfolio and impactful contributions to mental health medication. As pharmaceutical research continues to evolve, Maruyama's work remains influential in shaping effective treatment solutions for anxiety and psychiatric disorders. His legacy is a testament to the vital role of inventors in advancing healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…